Original Article
Author Details :
Volume : 3, Issue : 3, Year : 2016
Article Page : 357-361
Abstract
Background: Psoriatic arthritis is the major complication of psoriasis and the most common medication used for pain management is NSAID’s, followed by intra-articular steroids.
Aim: To compare the efficacy of intra articular Methylprednisolone with oral Etoricoxib in the pain management of Psoriatic arthritis.
Materials and Methods: A prospective comparative study was conducted in the pain clinic of department of Anaesthesiology for a period of one year. A total of 120 patients with psoriatic arthritis were included for the study. The patients were divided into 2 groups of 60 in each group. Group A patients received oral etoricoxib 120 mg OD for 6 weeks and the Group B patients received only one dose of intra-articular methyl prednisolone in the dosage of 20 mg (1 ml). All the patients were followed for a period of 6 weeks with 2 follow-up visits. The outcome measures adopted were visual analogue pain scale and psoriatic arthritis quality of life score.
Results: The baseline score of both visual analogue pain score and PsAQAL was found to be high and the score decreases during the 1st (1st week) and 2nd (6th week) follow-up (P<.05). The similar type of results was also observed for intra-articular methyl prednisolone. The follow-up visit showed that the methylprednisolone had a lower score than the patients who received etoricoxib both in the 1st week and 6th week of follow-up (p<.05).
Conclusion: The intra-articluar methylprednisolone was found to be more beneficial than etoricoxib in terms of reduced pain score and psoriatic arthritis quality of life score.
Keywords: Intra-articular methylprednisolone, Etoricoxib, Visual analogue pain scale, Psoriatic arthritis quality of life score
How to cite : Thilaak P, Kumar B A, Kannan G, Paul S, A comparative study on the efficacy of Intra articular Methylprednisolone with oral Etoricoxib in the pain management of Psoriatic arthritis. Indian J Clin Anaesth 2016;3(3):357-361
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.